Search arXivSearch

arXiv · 2402.10990

From parcels to people: development of a spatially explicit risk indicator to monitor residential pesticide exposure in agricultural areas

Abstract

The increase in global pesticide use has mirrored the rising demand for food over the last decades, resulting in a boost in crop yields. However, concerns about the impact of pesticides on biodiversity, ecosystems, and human health, especially for populations residing close to cultivated areas, are growing. This study investigates how exposure and possible risks to residents can be estimated at high spatial granularity based on plant protection product data. The complexities of such analysis were explored in France, where relevant data with good granularity are publicly available. Integrating sets of spatial datasets and exposure assessment methodologies, we have developed an indicator to monitor the levels of pesticide risk faced by residents. By spatialising pesticide sales data according to their authorization on specific crops, we developed a detailed map depicting potential pesticide loads at parcel level across France. This spatial distribution served as the basis for an exposure and risk assessment, modelled following the European Food Safety Authority's guidelines. Combining the risk map with population distribution data, we have developed an indicator that allows to monitor patterns in non-dietary exposure to pesticides. Our results show that in France, on average, 13% of people might be exposed to pesticides due to living in the proximity to treated crops. This exposure is in the lower range for 34%, moderate range for 40% and higher range for 25% of the exposed population. The risk evaluation is based on worst case assumptions and values should not be taken as a regulatory risk assessment but as indicator to use, for example, for monitoring time trends. The purpose of this indicator is to demonstrate that more granular pesticide data can improve risk reduction strategies. Harmonized and high-resolution data can help in identifying regions where to focus on sustainable farming.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Francesco Galimberti, Stephanie Bopp, Alessandro Carletti, Rui Catarino, Martin Claverie, Pietro Florio, Alessio Ippolito, Arwyn Jones, Flavio Marchetto, Michael Olvedy, Alberto Pistocchi, Astrid Verhegghen, Marijn Van Der Velde, Diana Vieira, Raphael d'Andrimont. 2024-02-16. From parcels to people: development of a spatially explicit risk indicator to monitor residential pesticide exposure in agricultural areas. https://doi.org/10.1038/s41598-025-96928-1

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

High Reconstruction Quality and Restart Repeatability Do Not Guarantee Recovery of Ground-Truth Muscle Synergies

High reconstruction quality and agreement across repeated fits do not necessarily establish recovery of muscle synergies. We tested whether a variance-accounted-for (VAF)/elbow rule recovers the generating synergy count and spatial vectors, whether high restart repeatability indicates recovery, and how five design factors affect recovery. Non-negative matrix factorisation was applied to 4,320 synthetic 16-muscle datasets varying generating rank, noise, trial count, spatial similarity and activation overlap. Combined recovery required the correct rank and cosine similarity of at least 0.80 for every matched spatial vector. Factor effects and two-factor interactions were assessed using exploratory heteroscedastic Wald tests with Benjamini-Hochberg adjustment. Rank selection was exact in 17.6% of datasets, too low in 54.9% and too high in 27.5%; combined recovery was 13.9%. Among fits with VAF at least 0.90, only 11.3% achieved combined recovery. Among 3,762 datasets with spatial repeatability at least 0.95, 19.6% had the correct rank and 15.7% achieved combined recovery. All five factors were associated with recovery (adjusted p < 0.001). Recovery declined from 26.2% to 1.7% with increasing spatial similarity and from 26.2% to 2.2% with increasing activation overlap. It was lower at ranks 7-9 than at 3-5, increased from 11.0% with 3 trials to 15.8% with 80 trials, and varied non-monotonically with noise. Five noiseless signals synthesised from measured-sEMG reference factors also showed under-selection despite VAF above 0.918. Under this selector, high reconstruction quality and restart agreement were insufficient indicators of correct rank and spatial recovery. Muscle-synergy interpretation should account for rank sensitivity and the separability of spatial and activation patterns.

q-bio.QM

A hierarchical memory architecture overcomes context limits in long-horizon multi-agent computational modeling

Large language models (LLMs) demonstrate remarkable reasoning capabilities, yet their stateless architecture fundamentally limits deployment in long-horizon research workflows requiring multi-session continuity and quantitative rigor. Here we present Ensemble QSP, a multi-agent framework featuring a three-layer hierarchical memory architecture that bounds injected context (median 301 tokens, max 4,050) by capping state categories and evicting completed work. This enables continuous autonomous operation without context degradation. The system orchestrates five specialist worker agents under domain-expert principal investigators (PIs), enforcing physical constraints through physics-based checklists and structured domain knowledge. Comprehensive benchmarking demonstrates autonomous pharmacokinetic-pharmacodynamic (PKPD) model selection, improved parameter recovery relative to single-agent baselines, and robust interpretation of linguistically diverse prompts. Replication with open-weight models (DeepSeek-V4-Flash/Pro, Llama 3.1 70B) confirmed these architectural conclusions across PKPD modeling, literature synthesis, and PBPK model implementation, proving the framework is independent of proprietary LLMs. Feature-level ablations show that memory, retrieval, and PI oversight address distinct scientific failure modes, though underlying LLM capability remains consequential for stringent physical-consistency checks. The architecture is structurally agnostic to computational biology; adding a new scientific domain requires only a new PI-agent configuration.

q-bio.QM

Foundation-model-based multi-label phenotyping of combined hyperkinetic movement disorders

Movement disorders (MDs) frequently co-occur, yet phenomenological and severity assessment shows substantial inter-rater variability. Markerless video could improve reproducibility, but prior work is largely single-symptom, depends on standardized acquisition, and lacks validation and transfer across ages and sites. We combined two foundation models into one frozen backbone: Segment Anything Model 3 (SAM 3) for dense, per-frame markerless segmentation summarized into geometric, contour and grid kinematic signals, and TabICLv2, a tabular foundation model, for in-context multi-label classification of eight hyperkinetic MD phenomenologies. Trained on standardized recordings of 21 adults and 4 controls, it transferred unchanged to two independent datasets, pediatric (n=12) and tremor-dominant adult (n=20), assessed with the CODY-SAMP scale; only the patient-level decision step was recalibrated per site. Under clinician consensus labels, false positives fell to zero in both datasets. Dystonia recovered perfectly (7/7 pediatric; 15/15 adult held-out), chorea fully in children (3/3), and tremor was recovered in adults (11/15) once a tremor-rich cohort made it evaluable, through recalibration alone. Per-region effect-size analysis gave clinically coherent, phenomenology-specific signals and identified myoclonus as the principal failure. Against YOLOv8 sparse keypoints, the dense representation matched under clinician permissive labels (Jaccard 0.63 vs 0.63) and was markedly more robust under clinician-label consensus (0.93 vs 0.76). This frozen foundation-model backbone with light per-site calibration yields transferable, interpretable, conservative multi-label phenotyping of co-occurring hyperkinetic MDs across ages and from standardized to routine video, adding robustness on high-confidence, clinician-agreed labels. Prospective multi-centre validation is required before clinical use.

q-bio.QM